{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:12:18Z","timestamp":1790208738783,"version":"4.1.0"},"reference-count":60,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2026,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study evaluated tislelizumab combined with low\u2010dose bevacizumab in recurrent glioblastoma (rGBM), assessing efficacy, safety, and mechanisms of immune escape.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This randomized phase 2 trial divided patients into treatment arms with distinct strategies. Longitudinal tumor in situ fluid (TISF) samples were collected for molecular analysis to monitor genome evolution. Immunohistochemical markers in paired primary and recurrent tumor specimens were analyzed to assess therapy\u2010induced immune resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 109 patients were included, with 59 in the control group and 50 in the experimental group. No grade 4 adverse events or treatment discontinuations occurred in the experimental group. The experimental group demonstrated a median overall survival of 13.3 months, compared to 6.6 months in the control group. The objective response rate and disease control rate were 32.6% and 79.1%, respectively. Post\u2010treatment TISF analysis revealed a 68.4% reduction in detectable genomic alterations. Immunophenotypic analysis of paired tumor samples showed increased infiltration of CD163\n                      <jats:sup>+<\/jats:sup>\n                      macrophages and elevated GDF\u201015 expression in recurrent tumors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study shows that combining tislelizumab and low\u2010dose bevacizumab improves survival in rGBM patients with good safety and tolerability. Dynamic changes in TISF\u2010based molecular markers reflect genomic evolution and predict prognosis. Increased CD163\n                      <jats:sup>+<\/jats:sup>\n                      cell infiltration in recurrent tumors may activate M2 macrophages, promoting tumor growth and immune evasion. Elevated GDF\u201015 levels may further suppress antitumor immunity, facilitating immune escape.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cncr.70253","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:15:36Z","timestamp":1768407336000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dynamic signature for the effectiveness of anti\u2013PD\u20101 therapy combined with vascular normalization therapy in recurrent glioblastoma: A randomized phase 2 trial"],"prefix":"10.1002","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2549-4068","authenticated-orcid":false,"given":"Jiubing","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6634-1226","authenticated-orcid":false,"given":"Dayang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Henan University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobin","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Henan University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuai","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyue","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijiao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology Zhengzhou University People's Hospital Henan University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pathology Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-9742","authenticated-orcid":false,"given":"Xingyao","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province Glioma Clinical Diagnosis and Treatment Center of Henan Province Zhengzhou University People's Hospital Henan Provincial People's Hospital  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa106"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020174"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.10.050"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010023\u201002347\u2010y"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20102045(17)30194\u20108"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.19.8721"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.Ccr\u201021\u20102241"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1308345"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707358"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104819"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008\u20105472.Can\u201010\u20100153"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215397109"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.Ccr\u201010\u20101868"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060\u2010023\u201004248\u2010z"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox208"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.08.004"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc\u20102022\u2010005829"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01926"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.05.005"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.4003"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj\u20102023\u2010078876"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943\u2010021\u201001489\u20102"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943\u2010022\u201001526\u20108"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.956"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.567"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262\u2010024\u201003774\u20107"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21586"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000002993"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326\u20106066.Cir\u201014\u20100053"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12624"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4236"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326\u20106066.Cir\u201020\u20100196"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1238607"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432\u2010024\u201005997\u20108"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.02017"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.01059"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad189"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010024\u201008305\u2010z"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432\u2010024\u201005777\u20104"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.5370"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not040"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.Ccr\u201021\u20102664"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20102045(18)30675\u20102"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060\u2010016\u20102288\u20105"},{"issue":"8","key":"e_1_2_9_46_1","first-page":"3487","article-title":"Sorafenib plus daily low\u2010dose temozolomide for relapsed glioblastoma: a phase II study","volume":"33","author":"Zustovich F","year":"2013","journal-title":"Anticancer Res"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1525243"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature22396"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.1024"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.009"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.Ccr\u201019\u20102179"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc\u20102019\u2010000453"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885\u2010023\u201011043\u20106"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.02.006"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010020\u201020469\u20106"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa256"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci163447"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045\u2010024\u201001544\u20107"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.534761"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00951"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010023\u201039817\u20103"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70253","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cncr.70253","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T18:45:01Z","timestamp":1772995501000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.70253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,15]]}},"alternative-id":["10.1002\/cncr.70253"],"URL":"https:\/\/doi.org\/10.1002\/cncr.70253","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"2025-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70253"}}